Please wait while the formulary information is being retrieved.
KETAMINE HCL-0.9% NACL (KETAMINE HCL IN 0.9 % SODIUM CHLORIDE)
- Ketamine In 0.9 % Sodium Chloride Intravenous Syringe
- Ketamine In 0.9 % Sodium Chloride Intravenous Solution
ketamine 10 mg/mL in 0.9 % sodium chloride intravenous syringe
- Dosage information is not available
ketamine 100 mg/10 mL (10 mg/mL) in 0.9 % sodium chloride IV syringe
- Dosage information is not available
ketamine 20 mg/2 mL (10 mg/mL) in 0.9 % sodium chloride IV syringe
- Dosage information is not available
ketamine 50 mg/5 mL (10 mg/mL) in 0.9 % sodium chloride IV syringe
- Dosage information is not available
ketamine 60 mg/20 mL (3 mg/mL) in 0.9 % sodium chloride IV syringe
- Dosage information is not available
ketamine 2 mg/mL in 0.9 % sodium chloride intravenous solution
- Dosage information is not available
- None
Contraindicated
- memantine
- Namenda
- Namenda Titration Pak
- Namenda Xr
- sodium oxybate
- Xyrem
Severe
Moderate
- None
- Acute decompensated heart failure
- Severe uncontrolled hypertension
Contraindicated
- Cardiac decompensation
- Delirium
- Respiratory depression
Severe
Moderate
- Acute confusion
- Alcohol intoxication
- Alcoholism
- Increased cerebrospinal fluid pressure
- Ocular hypertension
KETAMINE HCL-0.9% NACL (KETAMINE HCL IN 0.9 % SODIUM CHLORIDE)
- Hypertension
- Tachycardia
- Vocalization
- Acute confusion
- Delirium
- Hallucinations
- Tremor
More Frequent
Severe
Less Severe
- Bradycardia
- Hypotension
- Respiratory depression
- Erythema
- Hypertonia
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Apnea
- Cardiac arrhythmia
- Cystitis
- Hematuria
- Hydronephrosis
- Increased cerebrospinal fluid pressure
- Laryngismus
Less Severe
- Anorexia
- Diplopia
- Dysuria
- Increased urinary frequency
- Injection site sequelae
- Nausea
- Nystagmus
- Ocular hypertension
- Skin rash
- Urinary urge incontinence
Contraindicated
None
Severe Precaution
Ketamine
Risk of long-term cognitive deficit if duration exceeds 3 hrs and age < 3 years.
- 1 Day – 3 Years
- Risk of long-term cognitive deficit if duration exceeds 3 hrs and age < 3 years.
Management or Monitoring Precaution
None
Ketamine Hydrochloride
- Severity Level:
2
- Additional Notes: Insufficient human data available; animal data sug dev tox
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Ketamine
Unlikely clinically significant amount excreted
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Unlikely clinically significant amount excreted |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool